RHY — Rhythm Biosciences Share News
0.000.00%
Last trade - 00:00- AU$22.94m
- AU$19.74m
- AU$1.74m
Brief: Rhythm Biosciences Enters Service Agreement At Memorial Sloan Kettering Cancer Center
Brief: Rhythm Biosciences Receives Tranche Of A$1M In Non-Dilutive Funding From Endpoints Capital
Brief: Rhythm Biosciences Says Gavin Fox-Smith To Assume Role Of Chairman
Brief: Rhythm Biosciences Appoints Todd Perkinson As CFO
Brief: Rhythm Biosciences Acquires Genetype Genetic Risk Assessment Business
Brief: Rhythm Biosciences Says Susan Macleman Steps Down From Deputy Chair
Brief: Rhythm Biosciences Says To Raise A$3.5 Million At A$0.10 Per Share
Brief: Rhythm Biosciences Seeks Trading Halt
Brief: Rhythm Biosciences Says Otto Buttula To Step Down From Position Of Chair
Brief: Rhythm Biosciences Says Otto Buttula To Revert Back To Non-Executive Chair
Brief: Rhythm Biosciences Appoints David Atkins As CEO
Brief: Rhythm Biosciences Sats Significant Cost Reduction Program Continues
Brief: Rhythm Biosciences Says Rights Issue Offer To Raise Up To A$6.6 Million
Brief: Rhythm Biosciences Seeks Trading Halt
Australia's Rhythm Biosciences hits over 3-year low on nil product revenue forecast
Brief: Rhythm Biosciences Says Paul Smith, CFO And Joint Co Secretary Has Resigned
Australia's Rhythm Biosciences up on positive study results for breast cancer diagnostics
Brief: Rhythm Biosciences Posts FY Loss From Ordinary Activities After Tax Attributable A$8.2 Mln
Brief: Rhythm Biosciences Says Appointment Of Independent Deputy Chair